
Univ.-Prof. Dr. Gerald Gartlehner, MPH
Departmentleiter - Department für Evidenzbasierte Medizin und Evaluation
- gerald.gartlehner@donau-uni.ac.at
- +43 2732 893-2910
- +43 2732 893-4910 (Fax)
- Zum Kontaktformular
- Campus Krems, Trakt X, 1. Stock, 009
- Universität für Weiterbildung Krems
- Department für Evidenzbasierte Medizin und Evaluation
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Österreich
Funktionen
Leiter des Departments für Evidenzbasierte Medizin und Evaluation an der Donau-Universität Krems
Direktor von Cochrane Österreich
Stellvertretender Direktor des Research Triangle Institute International– University of North Carolina Evidence-based Practice Center, USA
Arbeits- und Forschungsschwerpunkte:
Evaluierung der vergleichenden Wirksamkeit und Sicherheit von medizinischen Interventionen
Evidenzbasierte Präventionsmedizin, insbesondere Screening
Projekte (Auszug Forschungsdatenbank)
Post-Acute Sequelae of SARS CoV-2 infection (RECOVER)
Case study of a single-human, machine-assisted abstract screening approach
Rapid Reviews - Single Screening RCT classifier
Systematischer Review Point of Care Ultrasound
European Partnership on Competencies for High Value Cost Conscious Care 2018
Surgery or embolization for varicoceles in subfertile men
Erstellung einer systematischen Literatursuche für das österreichische Hebammengremium
Drug Effectiveness Review Project/Cooperation RTI
Publikationen (Auszug Forschungsdatenbank)
Dobrescu, A.I.; Ebenberger, A.; Harlfinger, J.; Griebler, U.; Klerings, I.; Nussbaumer-Streit, B.; Chapman, A.; Affengruber, L.; Gartlehner, G. (2022). Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure - A systematic review. Science of The Total Environment, Volume 806, Part 1: https://doi.org/10.1016/j.scitotenv.2021.150480
Gartlehner, G.; Emprechtinger, R.; Hackl, M.; Jutz, F.L.; Gartlehner, J.E.; Nonninger, J.N.; Klerings, I.; Dobrescu, A.I. (2022). Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis. BMJ Evidence-Based Medicine, Published Online First: 15 March 2022.: doi: 10.1136/bmjebm-2021-111846
Noel-Storr, A.; Gartlehner, G.; Dooley, G.; Persad, E.; Nussbaumer-Streit, B. (2022). Crowdsourcing the identification of studies for COVID-19-related Cochrane Rapid Reviews. Research Synthesis Methods, -: 1-10
Dobrescu, A.; Gartlehner, G.; Wagner, G.; Chapman, A.; Moick, S.; Kahwati, L. (2022). Targeted immune modulators for rheumatoid arthritis and ankylosing spondylitis: update. Center for Evidence-based Policy, Oregon Health & Science University, -: -
Akl, E.A.; Morgan, R.L.; Rooney, A.A.; Beverly, B.; Katikireddi, S.V.; Agarwal, A.; Alper, B.S.; Alva-Diaz, C.; Amato, L.; Ansari, M.T.; Brozek, J.; Chu, D.K.; Dahm, P.; Darzi, A.J.; Falavigna, M.; Gartlehner, G.; Pardo-Hernandez, H.; King, V.; Klugarova, J.; Langendam, M.W.M.; Lockwood, C. (2021). Developing trustworthy recommendations as part of an urgent response (1e2 weeks): a GRADE concept paper. Journal of Clinical Epidemiology, 129: 1-11
Albritton, J.; Ortiz, A.; Wines, R.; Booth, G.; DiBello, M.; Brown, S.; Gartlehner, G.; Crotty, K. (2021). Video Teleconferencing for Disease Prevention, Diagnosis, and Treatment : A Rapid Review. Annals of Internal Medicine, 2021 Dec 7. Online ahead of: doi: 10.7326/M21-3511.
Dobrescu, A.; Nussbaumer-Streit, B.; Klerings, I.; Wagner, G.; Persad, E.; Sommer, I.; Herkner, H.; Gartlehner, G. (2021). Restricting evidence syntheses of interventions to English-language publications is a viable methodological shortcut for most medical topics: a systematic review. Journal of Clinical Epidemiology, 137: 209-217
Garritty, C.; Gartlehner, G.; Nussbaumer-Streit, B.; King, V.J.; Hamel, C.; Kamel, C.; Affengruber, L.; Stevens, A. (2021). Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. Journal of Clinical Epidemiology, 130: 13-22
Gartlehner, G.; Crotty, K.; Edlund, M.J.; Viswanathan, M. (2021). Authors' Reply to Pereira Ribeiro et al.: Comment on "Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis". CNS Drugs, Online ahead of print.: DOI: 10.1007/s40263-021-00873-2
Gartlehner, G.; Crotty, K.; Kennedy, S.; Edlund, M.J.; Ali, R.; Siddiqui, M.; Fortman, R.; Wines, R.; Persad, E.; Viswanathan, M. (2021). Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis. CNS Drugs, https://doi.org/10.1007/s40263-021-00855-4: https://doi.org/10.1007/s40263-021-00855-4
Noel-Storr A.; Dooley G.; Featherstone R.; Wisniewski S.; Shemilt I.; Thomas J.; Gartlehner, G.; Nussbaumer-Streit, B.; Mavergames, C. (2021). Crowdsourcing and COVID-19: a case study of Cochrane Crowd. Journal of the European Association for Health Information and Libraries (EAHIL), 17: 2
Noel-Storr, A.; Dooley, G.; Affengruber, L.; Gartlehner, G. (2021). Citation screening using crowdsourcing and machine learning produced accurate results: Evaluation of Cochrane’s modified Screen4Me service. Journal of Clinical Epidemiology, 130: 23-31
Nußbaumer-Streit, B.; Ellen, M.; Klerings, I.; Sfetcu, R.; Riva, N.; Mahmic-Kaknjo, M.; Poulentzas, G.; Martinez, P.; Baladia, E.; Ziganshina, L.E.; Marques, M.E.; Aguilar, L.; Kassianos, A.P.; Frampton, G.; Silva, A.G.; Affengruber, L.; Spjker, R.; Thomas, J.; Berg, R.C.; Kontogiani, M.; Sousa, M.; Kontogiorgis, C.; Gartlehner, G.; (2021). Resource use during systematic review production varies widely: a scoping review. Journal of Clinical Epidemiology, In Press, Corrected Proof: https://doi.org/10.1016/j.jclinepi.2021.05.019
Nußbaumer-Streit, B.; Thaler, K.; Chapman, A.; Probst, T.; Winkler, D.; Sönnichsen, A.; Gaynes, B.N.; Gartlehner, G. (2021). Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD008591.: 1465-1858
Nußbaumer-Streit, B.; Ziganshina, L.E.; Mahmic-Kaknjo, M.; Gartlehner, G.; Sfetcu, R.; Lund, H.; (2021). Resource use during systematic review production varies widely: a scoping review: authors’ reply. Journal of Clinical Epidemiology, 12: 15
Sommer, I.; Nussbaumer-Streit, B.; Gartlehner, G. (2021). WHO-Leitlinie: Körperliche Aktivität, Bewegungsmangel und Schlaf für Kinder unter 5 Jahren. Gesundheitswesen, efirst: 10.1055/a-1489-8049
Sommer, I.; Titscher, V.; Szelag, M.; Gartlehner, G. (2021). What are the Relevant Outcomes of the Periodic Health Examination? A Comparison of Citizens' and Experts' Ratings. Patient Prefer Adherence, 15: 57-68
Stamm, T.A.; Andrews, M.R.; Mosor, E.; Ritschl, V.; Li, L.C.;; Ma, J.K.; Campo-Arias, A.; Baker, S.; Burton, N.W. Eghbali, M.; Fernandez, N.; Ferreira, R.J.O.; Gäbler, G.; Makri, S.; Mintz, S.; Moe, R.H.; Morasso, E.; Murphy, S.L.; Ntuli, S.; Omara, M.; Simancas-Pallares, M.A.; Horonieff, J.; Gartlehner, G. (2021). The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review. Journal of Clinical Epidemiology, 135: 125-135
Van den Nest, M.; Wagner, G.; Riesenhuber, M.; Dolle, C.; Presterl, E.; Gartlehner, G.; Moertl, D.; Willinger, B. (2021). Filamentous Fungal Infections in a Tertiary Care Setting: Epidemiology and Clinical Outcome. Journal of Fungi, 7: 40
Wagner, G.; Moertl, D.; Glechner, A.; Mayr, V.; Klerings, I.; Zachariah, C.; Van den Nest, M.; Gartlehner, G.; Willinger, B. (2021). Paracoccidioidomycosis Diagnosed in Europe—A Systematic Literature Review. Journal of Fungi, 7(2), 157: https://doi.org/10.3390/jof7020157
Vorträge (Auszug Forschungsdatenbank)
Targeted Immune Modulators for Rheumatoid Arthritis and Ankylosing Spondylitis.
DERP Governance Call, 03.03.2022
Nonpharmacological Versus Pharmacological Treatments for Adult Patients with Major Depressive Disorder
ACP CGC Findings Presentation: Depression SR and NMA, 26.01.2022
Wie evidenzbasiert ist Präventionsmedizin?
Praevenire Initiative Gesundheit 2030, 19.05.2021
Evidenz und Pandemie
Treffen der Subkommende Wien und Niederösterreich des Johanniterordens, 09.03.2021
Live Talk COVID-19 - "Lessons learned"
22. Jahrestagung EbM Netzwerk 2021, 01.03.2021
Prädiktoren von falsch ausgeschlossenen Studien bei der Literaturdurchsicht von systematischen Reviews: ein systematischer Review und eine Methodenstudie
22. Jahrestagung EbM-Kongress 2021, 25.02.2021
Aktuelle COVID-19 Lage
Lagebesprechnung "NÖ testet, NÖ impft", 19.02.2021
Adverse Effects of Vaccines - Scientific Evidence versus Conspiracy Beliefs
Rotary Club Österreich, 18.01.2021
Unerwünschte Impfwirkungen, Impfschäden, falsche Fakten und Verschwörungstheorien.
Österreichische Apothekerkammer, 07.11.2020
Quarantänemaßnahmen und universelles Screening bei COVID-19
ÖGEpi Web-Meeting "COVID-19: ein Stresstest für die Epidemiologie?", 21.10.2020
Identifying predictors of missed studies in the abstract screening process and methods to find missed studies
Cochrane Colloquium (cancelled), 04.10.2020
Targeted Immune Modulators for Rheumatoid Arthritis and Ankylosing Spondylitis.
Online Präsentation für das Washington State P&T Committee Meeting, 17.06.2020
Cochrane Rapid Reviews - a response to COVID-19
AHRQ Evidence-based Practice Center Spring Meeting, 04.06.2020
The accuracy of single- vs. dual-reviewer abstract screening: a crowd-based randomized controlled trial.
21. Jahrestagung EbM-Netzwerk 2020, 14.02.2020
Point-of-care Ultrasonography for Acute Dyspnea. A Systematic Review and Meta-analysis.
Meeting of the American College of Physicians Guideline Panel, Philadelphia, USA, 29.01.2020
"Evidence-based Medicine can harm your health" - Cochrane Austria's battle against fake health news.
Herbstseminar d. Wiener Biometrischen Sektion: "Update in Evidence Synthesis Methods - Current Topics in Meta-analysis", Medical University Vienna, Ö., 13.11.2019
Screening for hypertension in children and adolescents.
Meeting of the United States Preventive Services Task Force, Bethesda, USA, 30.10.2019
VU 2020 Empfehlungen des ExpertInnengremiums
Hauptverband der österreichischen Sozialversicherungsträger, Sitzung der leitenden ÄrztInnen, Wien, Österreich, 25.07.2019
Does the pill against lovesickness work? Responding to inquiries from the general public with existing evidence
Evidence Live, Oxford, UK, 15.07.2019
Evidence-based Decision Making
Workshop beim 5th Congress of the European Academy of Neurology, Oslo, Norway, 28.06.2019
Tags